Trials / Completed
CompletedNCT00858195
A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules
A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indomethacin 75mg Extended-Release Capsules, Sandoz | |
| DRUG | Indocin 75mg SR Capsules |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2009-03-09
- Last updated
- 2017-03-29
Source: ClinicalTrials.gov record NCT00858195. Inclusion in this directory is not an endorsement.